chlorquinaldol structure
|
Common Name | chlorquinaldol | ||
---|---|---|---|---|
CAS Number | 72-80-0 | Molecular Weight | 228.075 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 350.7±37.0 °C at 760 mmHg | |
Molecular Formula | C10H7Cl2NO | Melting Point | 108-112 °C (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 165.9±26.5 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of chlorquinaldolChlorquinaldol is a mono-hydroxyquinoline, is an antifungal and antibacterial, used for topical treatment of skin conditions and vaginal infections. |
Name | chlorquinaldol |
---|---|
Synonym | More Synonyms |
Description | Chlorquinaldol is a mono-hydroxyquinoline, is an antifungal and antibacterial, used for topical treatment of skin conditions and vaginal infections. |
---|---|
Related Catalog |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 350.7±37.0 °C at 760 mmHg |
Melting Point | 108-112 °C (dec.)(lit.) |
Molecular Formula | C10H7Cl2NO |
Molecular Weight | 228.075 |
Flash Point | 165.9±26.5 °C |
Exact Mass | 226.990463 |
PSA | 33.12000 |
LogP | 4.21 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.679 |
Storage condition | 2-8°C |
Water Solubility | Insoluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P301 + P312 + P330 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn:Harmful |
Risk Phrases | R22;R36/37/38 |
Safety Phrases | S26-S36-S36/37/39 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | VC5600000 |
HS Code | 2933499090 |
~62% chlorquinaldol CAS#:72-80-0 |
Literature: Organic Letters, , vol. 16, # 3 p. 864 - 867 |
~% chlorquinaldol CAS#:72-80-0 |
Literature: CH229982 , ; |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Purity determination of gynalgin bactericidal tablets with HPLC method.
Acta Pol. Pharm. 70(1) , 51-8, (2013) The study was aimed at developing a simple HPLC method for the determination of the content of impurities in Gynalgin, a two-component preparation. A satisfactory separation was performed on 250 x 4.6... |
|
[Allergies to 8-hydroxyquinoline derivatives].
Derm. Beruf Umwelt. 36(3) , 86-90, (1988) Evaluation of our standardized test results from 1972 to 1983 indicated Vioform allergies in 1.2% of all cases and Sterosan allergies in 1.1%. Our results are within the spectrum found in the literatu... |
|
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.
Antimicrob. Agents Chemother. 51 , 1105-6, (2007) The in vitro activities of cloxyquin (5-chloroquinolin-8-ol) against 9 standard strains and 150 clinical isolates of Mycobacterium tuberculosis were studied. The MICs ranged from 0.062 to 0.25 microg/... |
5,7-Dichloro-2-methyl-8-quinolinol |
5,7-Dichloro-8-hydroxyquinaldine |
2-methyl-5,7-dichloro-8-hydroxyquinoline |
5,7-Dichloro-8-quinaldinol |
Clorquinaldol |
Chloroquinaldol |
EINECS 200-789-3 |
Gynotherax |
5,7-dichloro-2-methylquinolin-8-ol |
2-methylchloroxine |
5,7-Dichlor-2-methylchinolin-8-ol |
Saprosan |
Sterosan |
5,7-dichloro-2-methyl-8-hydroxy-quinoline |
8-Quinolinol, 5,7-dichloro-2-methyl- |
chlorquinaldol |
Chlorchinaldolum |
Chlorquinaldolum |
MFCD00023984 |